Microarray chemiluminescence-based immunoassay kit for simultaneous detection of multiple tumor-related biomarkers. The kit utilizes the company's proprietary hard substrate platform with high antibody loading capacity for improved analytical performance.
Manufactured by
China
Sunlant Bioengineering is a company specializing in chemiluminescent immunoassay technology, multi-index parallel detection, and fully automatic protein chip analysis for systematic detection of major diseases. The company focuses on two core diagnostic businesses: microarray chemiluminescent diagnostics and microbial identification/antimicrobial susceptibility testing systems, holding multiple "863 Program" achievements and over 100 patents.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 2 relevant products
SHMY HEALTHDIGIT BIOCHIPS CO.,LTD
China · 1 relevant product
GESIM Gesellschaft für Silizium-Mikrosysteme mbH
Germany · 3 relevant products
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 74 closest product alternatives
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying and quantifying cancer-related biomarkers. Supports oncology diagnosis, prognosis, and treatment monitoring.
SHMY HEALTHDIGIT BIOCHIPS CO.,LTD · China
Multi-tumor marker detection kit utilizing protein chip technology with chemiluminescence for simultaneous identification of multiple cancer biomarkers in blood and serum samples. Designed for clinical diagnosis and monitoring of various malignancies, this in vitro diagnostic test enables rapid quantitative analysis to support oncology patient management and treatment decisions.
GESIM Gesellschaft für Silizium-Mikrosysteme mbH · Germany
Comprehensive diagnostic test platform utilizing microarray technology for detection of multiple disease markers simultaneously. Requires high-precision liquid handling for accurate kit manufacturing.
71 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products